Dolsten Mikael
SEC-identified person · CIK 1437590 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Agilent Technologies, INC. A | Director | filed 2021–2026 |
| Apellis Pharmaceuticals, Inc. APLS | Director | filed 2026–2026 |
| Rocket Pharmaceuticals, INC. RCKT | Director | filed 2024–2025 |
| Pfizer INC pfe | Senior Vice President | filed 2009–2024 |
| Karyopharm Therapeutics Inc. KPTI | Director | filed 2015–2021 |
| Wyeth WYE | Sr. VP & Pres., Wyeth Research | filed 2008–2009 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.